Jeffrey L. Ives
CIK 1614096 · last filed 2026-06-05
Jeffrey L. Ives is a corporate insider who has filed 34 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for ABOS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $114.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$114.5K
2
34
-$1.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABOS | Director | 48,300 | $2.37 | $114.5K | -$272.3K | 7 | 2026-06-05 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | Director | 198,485 | $15.96 | $3.17M | -$785.5K | 27 | 2024-06-06 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | ABOS | Grant (A) | +35,500 | $0 | EDGAR |
| 2025-06-05 | ABOS | Grant (A) | +12,800 | $0 | EDGAR |
| 2024-06-10 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +150,647 | $0 | EDGAR |
| 2023-08-18 | ABOS | Mixed | — | -$240.8K | EDGAR |
| 2023-06-07 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +32,362 | $0 | EDGAR |
| 2022-07-19 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −3,600 | -$32.6K | EDGAR |
| 2022-06-17 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +11,876 | $0 | EDGAR |